Biotech · Private company
Adrenas Therapeutics Inc
Track this companyFree. Adds Adrenas Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AAV BBP-631Phase 2 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Pre-ScreeningCongenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 1, 2021ClinicalTrials.gov NCT04783181 · fetched Nov 12, 2026
- A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])COMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT05101902 · fetched Nov 12, 2026